The iconic rise of Viagra has consistently remained a benchmark of pharmaceutical success, yet its future within the broader industry now triggers questions about long-term returns . Generic versions are diminishing market share, prompting concerns that betting on companies significantly dependent to Viagra's previous influence could be a problemat